![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 2, 1323-1327, January 10, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Retroviral integrase, one of only three enzymes
encoded by the virus, catalyzes the essential step of inserting a DNA
copy of the viral genome into the host during infection. Using the avian sarcoma virus integrase, we demonstrate that the enzyme functions
as a tetramer. In presteady-state active site titrations, four
integrase protomers were required for a single catalytic turnover.
Volumetric determination of integrase-DNA complexes imaged by atomic
force microscopy during the initial turnover additionally revealed
substrate-induced assembly of a tetramer. These results suggest that
tetramer formation may be a requisite step during catalysis
with ramifications for antiviral design strategies targeting the
structurally homologous human immunodeficiency virus, type 1 (HIV-1) integrase.
Functional Oligomeric State of Avian Sarcoma Virus Integrase*
,
,
Department of Biochemistry and Biophysics,
Oregon State University, Corvallis, Oregon 97331, the
§ Department of Chemistry, University of North Carolina at
Chapel Hill, Chapel Hill, North Carolina 27599, and the
¶ Institute for Cancer Research, Fox Chase Cancer Center,
Philadelphia, Pennsylvania 19111
*
This work was supported by National Institutes of Health
Grant GM58771 (to I. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Biochemistry and Biophysics, Oregon State University, 2011 ALS Bldg., Corvallis, OR 97331. E-mail: wongis@onid.orst.edu.
This article has been cited by other articles:
![]() |
L. Chelico, E. J. Sacho, D. A. Erie, and M. F. Goodman A Model for Oligomeric Regulation of APOBEC3G Cytosine Deaminase-dependent Restriction of HIV J. Biol. Chem., May 16, 2008; 283(20): 13780 - 13791. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baranova, F. V. Tuzikov, O. D. Zakharova, N. A. Tuzikova, C. Calmels, S. Litvak, L. Tarrago-Litvak, V. Parissi, and G. A. Nevinsky Small-angle X-ray characterization of the nucleoprotein complexes resulting from DNA-induced oligomerization of HIV-1 integrase Nucleic Acids Res., February 16, 2007; 35(3): 975 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Q. Al-Mawsawi, V. Fikkert, R. Dayam, M. Witvrouw, T. R. Burke Jr., C. H. Borchers, and N. Neamati From the Cover: Discovery of a small-molecule HIV-1 integrase inhibitor-binding site PNAS, June 27, 2006; 103(26): 10080 - 10085. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vera, V. Parissi, A. Garcia, R. Zuniga, M.-L. Andreola, A. Caumont-Sarcos, L. Tarrago-Litvak, and O. Leon Yeast system as a model to study Moloney murine leukemia virus integrase: expression, mutagenesis and search for eukaryotic partners J. Gen. Virol., September 1, 2005; 86(9): 2481 - 2488. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.él. Faure, C. Calmels, Céc. Desjobert, M. Castroviejo, A. Caumont-Sarcos, L. Tarrago-Litvak, S. Litvak, and V. Parissi HIV-1 integrase crosslinked oligomers are active in vitro Nucleic Acids Res., February 17, 2005; 33(3): 977 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Marchand, A. A. Johnson, R. G. Karki, G. C. G. Pais, X. Zhang, K. Cowansage, T. A. Patel, M. C. Nicklaus, T. R. Burke Jr., and Y. Pommier Metal-Dependent Inhibition of HIV-1 Integrase by {beta}-Diketo Acids and Resistance of the Soluble Double-Mutant (F185K/C280S) Mol. Pharmacol., September 1, 2003; 64(3): 600 - 609. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |